Playlist

Turkmen Doctor Receives Two Prestigious Awards at CIS International Contest

13 Apr. 06:48

Source

Nowruz Myratdurdyýew, a senior specialist at the Myrat Garryýew State Medical University of Turkmenistan, achieved remarkable success at an international competition held in Astana, Kazakhstan. Participating in a CIS-wide program, he secured two prestigious titles simultaneously: "Best Teacher of the CIS" and "Best Young Scientist of the CIS." This dual recognition highlights the excellence of Turkmenistan’s medical education and its growing influence within the regional scientific community.

The competition, organized by Kazakhstan’s leading innovation centers, aimed to identify and honor the most talented educators and young researchers across the Commonwealth of Independent States. Myratdurdyýew was highly commended by the jury for his advanced socio-pedagogical techniques and his scientific research focused on the lexical characteristics of medical proverbs in foreign languages. His work effectively bridges the gap between linguistics and medical science, offering new insights into professional terminology.

Following the competition results, the Turkmen scholar was presented with a first-degree diploma, a commemorative badge, and an international certificate of merit. This victory serves as a testament to the high standards of academic and scientific training provided at Turkmenistan’s medical institutions and further strengthens the country’s educational ties within the CIS region.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌